Vision and mission

Immunovia’s vision is to lead the way in bioinformatic-assisted diagnostics towards a future where all patients are diagnosed in time for effective treatment, better quality of life and significantly improved survival rates.

Therefore, our missions are:

  1. To discover, develop and establish more accurate and reliable tools for the early diagnosis of cancers and autoimmune disorders based on the IMMray™ platform to enable more effective treatment and better patient outcomes.
  2. To establish our blood-based test for the early diagnosis of pancreatic cancer – IMMray™ PanCan-d – as a global standard for detecting pancreatic cancer in high-risk groups much earlier than is possible today.

Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports